DH Fundamental Analysis - DEFINITIVE HEALTHCARE CORP

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to DH. DH was compared to 35 industry peers in the Health Care Technology industry. DH may be in some trouble as it scores bad on both profitability and health. DH has a valuation in line with the averages, but on the other hand it scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DH was profitable.

DH had a positive operating cash flow in the past year.

DH had negative earnings in each of the past 5 years.

In the past 5 years DH always reported a positive cash flow from operatings.

1.2 Ratios

DH's Return On Assets of -39.57% is on the low side compared to the rest of the industry. DH is outperformed by 72.22% of its industry peers.

DH's Return On Equity of -100.37% is on the low side compared to the rest of the industry. DH is outperformed by 72.22% of its industry peers.

		Industry Rank	Sector Rank
ROA	-39.57%
ROE	-100.37%
ROIC	N/A

ROA(3y)-16.45%

ROA(5y)-10.62%

ROE(3y)-39.07%

ROE(5y)-24.71%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 76.35%, DH belongs to the top of the industry, outperforming 86.11% of the companies in the same industry.

DH's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for DH so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	76.35%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.22%

GM growth 5Y0.01%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DH does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for DH has been reduced compared to 1 year ago.

The number of shares outstanding for DH has been increased compared to 5 years ago.

The debt/assets ratio for DH is higher compared to a year ago.

2.2 Solvency

DH has an Altman-Z score of -0.20. This is a bad value and indicates that DH is not financially healthy and even has some risk of bankruptcy.

DH has a Altman-Z score (-0.20) which is comparable to the rest of the industry.

DH has a debt to FCF ratio of 4.10. This is a neutral value as DH would need 4.10 years to pay back of all of its debts.

Looking at the Debt to FCF ratio, with a value of 4.10, DH is in the better half of the industry, outperforming 63.89% of the companies in the same industry.

A Debt/Equity ratio of 0.53 indicates that DH is somewhat dependend on debt financing.

DH has a Debt to Equity ratio of 0.53. This is in the lower half of the industry: DH underperforms 69.44% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.53
Debt/FCF	4.1
Altman-Z	-0.2

ROIC/WACCN/A

WACC9.7%

2.3 Liquidity

DH has a Current Ratio of 1.65. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.

DH's Current ratio of 1.65 is on the low side compared to the rest of the industry. DH is outperformed by 63.89% of its industry peers.

A Quick Ratio of 1.65 indicates that DH should not have too much problems paying its short term obligations.

DH's Quick ratio of 1.65 is on the low side compared to the rest of the industry. DH is outperformed by 63.89% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.65
Quick Ratio	1.65

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

DH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.09%.

DH shows a decrease in Revenue. In the last year, the revenue decreased by -5.24%.

The Revenue has been growing by 24.15% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-9.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-22.22%

Revenue 1Y (TTM)-5.24%

Revenue growth 3Y14.91%

Revenue growth 5Y24.15%

Sales Q2Q%-4.69%

3.2 Future

Based on estimates for the next years, DH will show a decrease in Earnings Per Share. The EPS will decrease by -4.78% on average per year.

DH is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.46% yearly.

EPS Next Y-32.85%

EPS Next 2Y-12.68%

EPS Next 3Y-4.78%

EPS Next 5YN/A

Revenue Next Year-4.79%

Revenue Next 2Y-2.09%

Revenue Next 3Y-0.46%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.53, DH is valued correctly.

97.22% of the companies in the same industry are more expensive than DH, based on the Price/Earnings ratio.

The average S&P500 Price/Earnings ratio is at 27.24. DH is valued rather cheaply when compared to this.

DH is valuated correctly with a Price/Forward Earnings ratio of 15.21.

DH's Price/Forward Earnings ratio is rather cheap when compared to the industry. DH is cheaper than 91.67% of the companies in the same industry.

DH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.81, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	13.53
Fwd PE	15.21

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DH is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.

DH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DH is cheaper than 91.67% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	14.02
EV/EBITDA	10.07

4.3 Compensation for Growth

A cheap valuation may be justified as DH's earnings are expected to decrease with -4.78% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-12.68%

EPS Next 3Y-4.78%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DH!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DEFINITIVE HEALTHCARE CORP

NASDAQ:DH (8/22/2025, 8:03:18 PM)

After market: 4.06 0 (0%)

4.06

+0.29 (+7.69%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)08-07 2025-08-07/amc

Earnings (Next)11-05 2025-11-05/amc

Inst Owners37.13%

Inst Owner Change-4.12%

Ins Owners7.57%

Ins Owner Change43.01%

Market Cap578.47M

Analysts74.29

Price Target4.57 (12.56%)

Short Float %14.66%

Short Ratio7.3

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)68.99%

Min EPS beat(2)36.39%

Max EPS beat(2)101.59%

EPS beat(4)4

Avg EPS beat(4)42.37%

Min EPS beat(4)9.63%

Max EPS beat(4)101.59%

EPS beat(8)6

Avg EPS beat(8)24.89%

EPS beat(12)10

Avg EPS beat(12)29.77%

EPS beat(16)12

Avg EPS beat(16)22.12%

Revenue beat(2)1

Avg Revenue beat(2)0.94%

Min Revenue beat(2)-0.4%

Max Revenue beat(2)2.29%

Revenue beat(4)1

Avg Revenue beat(4)0.08%

Min Revenue beat(4)-1.38%

Max Revenue beat(4)2.29%

Revenue beat(8)1

Avg Revenue beat(8)-1.12%

Revenue beat(12)2

Avg Revenue beat(12)-1.1%

Revenue beat(16)5

Avg Revenue beat(16)-0.73%

PT rev (1m)9.21%

PT rev (3m)-1.59%

EPS NQ rev (1m)-6.48%

EPS NQ rev (3m)-29.16%

EPS NY rev (1m)6.75%

EPS NY rev (3m)4.89%

Revenue NQ rev (1m)0.43%

Revenue NQ rev (3m)-1.48%

Revenue NY rev (1m)0.52%

Revenue NY rev (3m)0.68%

Valuation

		Industry Rank	Sector Rank
PE	13.53
Fwd PE	15.21
P/S	2.36
P/FCF	14.02
P/OCF	9.19
P/B	1.91
P/tB	N/A
EV/EBITDA	10.07

EPS(TTM)0.3

EY7.39%

EPS(NY)0.27

Fwd EY6.57%

FCF(TTM)0.29

FCFY7.13%

OCF(TTM)0.44

OCFY10.88%

SpS1.72

BVpS2.13

TBVpS-1.29

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-39.57%
ROE	-100.37%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	76.35%
FCFM	16.85%

ROA(3y)-16.45%

ROA(5y)-10.62%

ROE(3y)-39.07%

ROE(5y)-24.71%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.22%

GM growth 5Y0.01%

F-Score4

Asset Turnover0.32

Health

		Industry Rank	Sector Rank
Debt/Equity	0.53
Debt/FCF	4.1
Debt/EBITDA	3.51
Cap/Depr	39.87%
Cap/Sales	8.85%
Interest Coverage	N/A
Cash Conversion	137.79%
Profit Quality	N/A
Current Ratio	1.65
Quick Ratio	1.65
Altman-Z	-0.2

F-Score4

WACC9.7%

ROIC/WACCN/A

Cap/Depr(3y)14.76%

Cap/Depr(5y)11.57%

Cap/Sales(3y)3.27%

Cap/Sales(5y)3.01%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-9.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-22.22%

EPS Next Y-32.85%

EPS Next 2Y-12.68%

EPS Next 3Y-4.78%

EPS Next 5YN/A

Revenue 1Y (TTM)-5.24%

Revenue growth 3Y14.91%

Revenue growth 5Y24.15%

Sales Q2Q%-4.69%

Revenue Next Year-4.79%

Revenue Next 2Y-2.09%

Revenue Next 3Y-0.46%

Revenue Next 5YN/A

EBIT growth 1Y63.23%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-12.53%

EBIT Next 3Y-4.78%

EBIT Next 5YN/A

FCF growth 1Y67.56%

FCF growth 3Y35.38%

FCF growth 5Y18.42%

OCF growth 1Y88.1%

OCF growth 3Y32.16%

OCF growth 5Y21.93%

DEFINITIVE HEALTHCARE CORP (DH) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens